News
PSNL
1.290
+6.61%
0.080
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Ark Invest run by Tesla bull Cathie Wood bought 20,683 shares of Tesla on Monday. The stock settled the session down 2.71% at $157.11. Tesla is now the top holding of the firm's flagship exchange-traded fund. Tesla shares settled lower for a third session on Tuesday.
Benzinga · 3d ago
Weekly Report: what happened at PSNL last week (0408-0412)?
Weekly Report · 5d ago
Personalis Price Target Maintained With a $3.50/Share by Needham
Dow Jones · 04/11 12:26
Buy Rating Affirmed for Personalis, Inc. on Strong Growth Prospects and Innovative Cancer Assays
TipRanks · 04/11 12:25
Weekly Report: what happened at PSNL last week (0401-0405)?
Weekly Report · 04/08 12:18
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
Cathie Wood’s Ark Invest purchased 26,925 shares of Pinterest Inc (NYSE:PINS) on Wednesday. The investment firm made the purchase at a value of $949,914. Ark Invest has previously purchased over $23 million worth of Pinterest shares in February.
Benzinga · 04/04 02:17
Weekly Report: what happened at PSNL last week (0325-0329)?
Weekly Report · 04/01 12:14
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Cathie Wood-led Ark Invest purchased a substantial number of shares in Tesla Inc. On Thursday. The value of the Tesla shares bought by Ark Invest on Thursday is estimated to be around $14 million. This comes after the electric vehicle giant's stock price tumbled nearly 2.25%.
Benzinga · 03/29 02:09
Personalis Announces Publication Validating NeXT Personal Test For Ultra-Sensitive MRD Detection And Cancer Treatment Response Monitoring
Blood-based assay uses personalized tumor-informed approach designed to detect cancer recurrence early with an ultra-sensitive approach Personalis, Inc. Announced a new publication validating the company's NeXT Personal test. The test is designed to help detect minimal residual disease (MRD) and identify recurrence with high analytical sensitivity and accuracy.
Benzinga · 03/26 13:05
Weekly Report: what happened at PSNL last week (0318-0322)?
Weekly Report · 03/25 12:17
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Cathie Wood-led Ark Invest sold 42,608 shares of Block Inc for $3.5 million on Wednesday. The firm has sold Block shares in every trading session of the current week. The Block Inc trade comes amid Bitcoin prices recovering. Ark has also sold shares of Cerus Corp, Personalis and Moderna.
Benzinga · 03/21 03:40
Wednesday's ETF Movers: ILF, ARKG
NASDAQ · 03/20 16:35
XTIA, PSNL and LIDR among mid-day movers
On the Move XTIA, PSNL and LIDR among mid-day movers. Gainers: X.T. Biopharmaceuticals Ltd. And Anghami. Losers: Lifecore Biomedical, Airship AI Holdings and AISP.
Seeking Alpha · 03/20 16:25
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
Cathie Wood-led Ark Invest sold $7.5 million worth of shares of Block Inc on Tuesday. The sale occurred amidst a downturn in Bitcoin prices. The Jack Dorsey-led firm also sold $8.95 million of Block shares on Monday. Ark Invest's decision to sell off Block shares came as a surprise to many.
Benzinga · 03/20 04:29
Weekly Report: what happened at PSNL last week (0311-0315)?
Weekly Report · 03/18 12:16
Weekly Report: what happened at PSNL last week (0304-0308)?
Weekly Report · 03/11 12:10
Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
Cathie Wood-led Ark Invest sold 54,215 shares of Coinbase Global Inc on Thursday. The company also bought 19,749 shares of Palantir Technologies Inc for its ARK Space Exploration & Innovation ETF. The move came as Bitcoin was nearing a new all-time high.
Benzinga · 03/08 06:40
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Recent notable insider transactions for penny stocks include Aclaris Therapeutics, Lumen Technologies and Personalis.
Benzinga · 03/06 11:56
Weekly Report: what happened at PSNL last week (0226-0301)?
Weekly Report · 03/04 12:14
Buy Rating Affirmed: Personalis’s Strategic Advances and Financial Health Signal Promising Growth in 2024
TipRanks · 03/04 10:49
More
Webull provides a variety of real-time PSNL stock news. You can receive the latest news about Personalis through multiple platforms. This information may help you make smarter investment decisions.
About PSNL
Personalis, Inc. is engaged in developing and marketing advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies.